Aleix Prat

ScholarGPS® ID: 79736522729508

Affiliation

University of Barcelona, Barcelona, Catalonia, Spain

Affiliation History

Field

Medicine

Discipline

Oncology

Top Specialties

Metrics Summary

Publication Count

378

Predicted Citations

22,822

Predicted h-index

Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
“Positioning of tucatinib in the new clinical scenario of HER2-positive metastatic breast cancer: An Italian and Spanish consensus paper” (journal article) Conte, Pierfranco \| Ciruelos, Eva \| Curigliano, Giuseppe \| De Laurentiis, Michelino \| Del Mastro, Lucia \| Gennari, Alessandra \| Llombart, Antonio \| Martìn, Miguel \| Poggio, Francesca \| Prat, Aleix \| ... \| Saura, Cristina The Breast, volume 76 (2024). 10.1016/j.breast.2024.103742 Cite \| Source
The evolving landscape of metastatic HER2-positive, hormone receptor-positive Breast Cancer (journal article) Boscolo Bielo, Luca \| Trapani, Dario \| Nicolò, Eleonora \| Valenza, Carmine \| Guidi, Lorenzo \| Belli, Carmen \| Kotteas, Elias \| Marra, Antonio \| Prat, Aleix \| Fusco, Nicola \| ... \| Curigliano, Giuseppe Cancer Treatment Reviews, volume 128 (2024). 10.1016/j.ctrv.2024.102761 Cite \| Source
Computational model predicts patient outcomes in Luminal B breast cancer treated with endocrine therapy and CDK4/6 inhibition (journal article) Schmiester, Leonard \| Brasó-Maristany, Fara \| González-Farré, Blanca \| Pascual, Tomas \| Gavilá, Joaquín \| Tekpli, Xavier \| Geisler, Jürgen \| Kristensen, Vessela N. \| Frigessi, Arnoldo \| Prat, Aleix \| Köhn-Luque, Alvaro Clinical Cancer Research (2024). 10.1158/1078-0432.CCR-24-0244 Cite \| Source
487P HER2DX ERBB2 mRNA assay following trastuzumab-based chemotherapy in HER2-positive (HER2+) advanced gastric cancer (AGC) (journal article) Sauri Nadal, T. \| Pesantez Coronel, D.S. \| Braso Maristany, F. \| Indacochea, A. \| Cuatrecasas, M. \| Sanfeliu Torres, E. \| Lopezprades, S. \| Candia, L. \| Fernandez-Esparrach, G. \| Mendez, I. \| ... \| Prat, A. Annals of Oncology, volume 35 (2024). 10.1016/j.annonc.2024.05.399 Cite \| Source
CDK4/6-Inhibitors Versus Chemotherapy in Advanced HR+/HER2-Negative Breast Cancer: Results and Correlative Biomarker Analyses of the KENDO Randomized Phase II Trial (journal article) Schettini, Francesco \| Palleschi, Michela \| Mannozzi, Francesca \| Brasó-Maristany, Fara \| Cecconetto, Lorenzo \| Galván, Patricia \| Mariotti, Marita \| Ferrari, Alessia \| Scarpi, Emanuela \| Miserocchi, Anna \| ... \| De Giorgi, Ugo The Oncologist, volume 29, issue 5, pages e622-e634 (2024). 10.1093/oncolo/oyad337 Cited by (2) \| Cite \| Source
213P Sequencing antibody-drug conjugates (ADCs) in patients (pts) with HER2-negative (HER2-) metastatic breast cancer (mBC) (journal article) Morganti, S. \| Tarantino, P. \| Graham, N. \| Hughes, M. \| Kusmick, R. \| Smith, K. \| Suggs, G. \| Skeffington, M. \| Buck, S. \| Sendrick, K. \| ... \| Tolaney, S.M. ESMO Open, volume 9 (2024). 10.1016/j.esmoop.2024.103235 Cite \| Source
94P Biological effects of a pre-operative radiotherapy boost in early-stage breast cancer: Primary results of the YOUNGSTER unicentric single-arm clinical trial (journal article) Gomà, C. \| Brasó-Maristany, F. \| Oses, G. \| Torres, E. Sanfeliu \| Hernandez, A. Rodriguez \| Gonzalez-Farre, B. \| Llop-Guevara, A. \| Elizalde, V. Serra \| Ganau, S. \| Úbeda, B. \| ... \| Mollá, M. ESMO Open, volume 9 (2024). 10.1016/j.esmoop.2024.103165 Cite \| Source
49P A ctDNA tool for identifying ESR1-mutated biology in ESR1-non-mutated hormone receptor-positive (HR+) metastatic breast cancer (MBC) (journal article) Fructuoso, I. Garcia \| Martínez-Sáez, O. \| Pardo, F. \| Vega León, M.D.R. \| Matito, J. \| Brunet, L. Pare \| Castillo, O. \| Javierre, G. Villacampa \| Galván, P. \| Odegaard, J. \| ... \| Brasó-Maristany, F. ESMO Open, volume 9 (2024). 10.1016/j.esmoop.2024.103056 Cite \| Source
22P Unveiling biological and prognostic differences among premenopausal patients with hormone receptor-positive HER2-negative (HR+/HER2-) breast cancer (journal article) Walbaum, B. \| Chic, N. \| Bruñol, C. Crous \| Sola, J. \| Martínez-Sáez, O. \| Gomez-Bravo, R. \| Solís, E. Seguí \| García-Fructuoso, I. \| Pascual, T. \| Schettini, F. \| ... \| Losada, M.J. Vidal ESMO Open, volume 9 (2024). 10.1016/j.esmoop.2024.103030 Cite \| Source
10P PIK3CA mutation and response to neoadjuvant taselisib and endocrine therapy: A biomarker study of the LORELEI trial (journal article) Fimereli, D. \| Nuciforo, P.G. \| de Azambuja, E. \| Wilson, T. \| Prat, A. \| Filipits, M. \| Pfeiler, G. \| Aimi, J. \| Metcalfe, C. \| Stout, T.J. \| ... \| Sotiriou, C. ESMO Open, volume 9 (2024). 10.1016/j.esmoop.2024.103019 Cite \| Source
CAR affinity modulates the sensitivity of CAR-T cells to PD-1/PD-L1-mediated inhibition (journal article) Andreu-Saumell, Irene \| Rodriguez-Garcia, Alba \| Mühlgrabner, Vanessa \| Gimenez-Alejandre, Marta \| Marzal, Berta \| Castellsagué, Joan \| Brasó-Maristany, Fara \| Calderon, Hugo \| Angelats, Laura \| Colell, Salut \| ... \| Guedan, Sonia Nature Communications, volume 15, issue 1 (2024). 10.1038/s41467-024-47799-z Cited by (2) \| Cite \| Source
Management of early-stage HER2-positive breast cancer and attitudes towards HER2DX test in Spain: insights from a nationwide survey (journal article) Martínez-Sáez, Olga \| Cortés, Javier \| Ciruelos, Eva \| Marín-Aguilera, Mercedes \| González, Gloria \| Paré, Laia \| Herrera, Adriana \| Villagrasa-González, Patricia \| Prat, Aleix \| Martín, Miguel Clinical and Translational Oncology (2024). 10.1007/s12094-024-03409-4 Cite \| Source
Characterisation and Outcomes of Patients with Solid Organ Malignancies Admitted to the Intensive Care Unit: Mortality and Impact on Functional Status and Oncological Treatment (journal article) García de Herreros, Marta \| Laguna, Juan Carlos \| Padrosa, Joan \| Barreto, Tanny Daniela \| Chicote, Manoli \| Font, Carme \| Grafiá, Ignacio \| Llavata, Lucía \| Seguí, Elia \| Tuca, Albert \| ... \| Marco-Hernández, Javier Diagnostics, volume 14, issue 7, pages 730- (2024). 10.3390/diagnostics14070730 Cite \| Source
Intrinsic Subtype and Overall Survival of Patients with Advanced HR+/HER2− Breast Cancer Treated with Ribociclib and ET: Correlative Analysis of MONALEESA-2, -3, -7 (journal article) Prat, Aleix \| Solovieff, Nadia \| André, Fabrice \| O'Shaughnessy, Joyce \| Cameron, David A. \| Janni, Wolfgang \| Sonke, Gabe S. \| Yap, Yoon-Sim \| Yardley, Denise A. \| Partridge, Ann H. \| ... \| Carey, Lisa A. Clinical Cancer Research, volume 30, issue 4, pages 793-802 (2024). 10.1158/1078-0432.CCR-23-0561 Cited by (3) \| Cite \| Source
Identification of a novel prognostic gene signature in a clear cell renal cell carcinoma (ccRCC) population using an integrated multi-study single-cell RNAseq dataset. (journal article) García-Esteve, Samuel \| Jiménez, Natalia \| Aversa, Caterina \| Ferrer-Mileo, Laura \| Garcia de Herreros, Marta \| Fernandez-Mañas, Laia \| González-Aguado, Laura \| Rubio-Pérez, Carlota \| Cobo-Diego, Inés \| Mazariegos, Manuel \| ... \| Reig-Torras, Òscar Journal of Clinical Oncology, volume 42, issue 4_suppl, pages 465-465 (2024). 10.1200/JCO.2024.42.4_suppl.465 Cite \| Source
Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer (journal article) Dieci, Maria Vittoria \| Conte, PierFranco \| Bisagni, Giancarlo \| Bartolini, Stefania \| Frassoldati, Antonio \| Generali, Daniele \| Piacentini, Federico \| Griguolo, Gaia \| Tagliafico, Enrico \| Brasó Maristany, Fara \| ... \| Guarneri, Valentina JNCI: Journal of the National Cancer Institute, volume 116, issue 1, pages 69-80 (2024). 10.1093/jnci/djad179 Cited by (1) \| Cite \| Source
Neoadjuvant nivolumab + palbociclib + anastrozole for oestrogen receptor-positive/human epidermal growth factor receptor 2-negative primary breast cancer: Results from CheckMate 7A8 (journal article) Jerusalem, Guy \| Prat, Aleix \| Salgado, Roberto \| Reinisch, Mattea \| Saura, Cristina \| Ruiz-Borrego, Manuel \| Nikolinakos, Petros \| Ades, Felipe \| Filian, Jeiry \| Huang, Ning \| ... \| Tolaney, Sara M. The Breast, volume 72 (2023). 10.1016/j.breast.2023.103580 Cited by (3) \| Cite \| Source
Optimising of axillary therapy in breast cancer: lessons from the past to plan for a better future (journal article) Kaidar-Person, Orit \| Tramm, Trine \| Kuehn, Thorsten \| Gentilini, Oreste \| Prat, Aleix \| Montay-Gruel, Pierre \| Meattini, Icro \| Poortmans, Philip La radiologia medica, volume 129, issue 2, pages 315-327 (2023). 10.1007/s11547-023-01743-1 Cite \| Source
582 Analysis of the HR+/HER2- breast cancer tumor microenvironment following immune priming with pelareorep and atezolizumab using imaging mass cytometry – Results from the AWARE-1 trial (conference) Olea, Julian \| Dadrastoussi, Homa \| Hernandez, Eduardo Fernandez \| Martinez, Hugo Lara \| Wu, Kaijin \| Loghmani, Houra \| Heineman, Thomas \| Trauger, Richard \| Coffey, Matt \| Salvador, Fernando \| ... \| Kelly, Kevin SITC 38th Annual Meeting (SITC 2023) Abstracts (2023) 10.1136/jitc-2023-SITC2023.0582 Cite \| Source
MA14.08 Pathogenic Germline Variants in Patients with Non-Small Cell Lung Cancer (NSCLC) Detected by Tissue Comprehensive Genomic Profiling (journal article) Mezquita, L. \| Kuang, Z. \| Sivakumar, S. \| Sokol, E.S. \| Laguna, J.C. \| Pastor, B. \| Nalda, I. \| Turrisi, F. \| Aguilar, L. \| Arcocha, A. \| ... \| Besse, B. Journal of Thoracic Oncology, volume 18, issue 11, pages S151- (2023). 10.1016/j.jtho.2023.09.217 Cited by (2) \| Cite \| Source